Prostate Cancer Diagnostics Market

Prostate Cancer Diagnostics Market Analysis By Test Type (PSA, PCA3, CTC & Immunohistochemistry Prostate Cancer Diagnostic Test), By End User (Prostate Cancer Diagnostics in Hospitals, Prostate Cancer Diagnostics in Cancer Research Institutes) - Global Market insights 2021 to 2031

Analysis of Prostate Cancer Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Request FREE Sample

Table of Content

Chapter 1. Global Prostate Cancer Diagnostics Market - Executive Summary. 11

Chapter 2. Global Prostate Cancer Diagnostics Market Overview. 13

2.1. Introduction. 13

       2.1.1. Global Prostate Cancer Diagnostics Market Taxonomy. 13

       2.1.2. Global Prostate Cancer Diagnostics Market Definition. 13

2.2. Global Prostate Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2016-2031. 14

       2.2.1. Global Prostate Cancer Diagnostics Market Y-o-Y Growth. 14

2.3. Global Prostate Cancer Diagnostics Market Dynamics. 14

       2.3.1. Drivers. 14

       2.3.2. Restraints. 14

       2.3.3. Trends. 15

2.4. Supply Chain. 15

2.5. Epidemiology. 15

2.6. Key Participants Market Presence (Intensity Map) By Region. 15

Chapter 3. Global Prostate Cancer Diagnostics Market Analysis and Forecast By Test Type. 16

3.1. Global Prostate Cancer Diagnostics Market Size and Forecast By Test Type, 2016-2031. 16

       3.1.1. PSA Tests Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 16

                3.1.1.1. Revenue (US$ Mn) Comparison, By Region. 16

                3.1.1.2. Market Share Comparison, By Region. 18

                3.1.1.3. Y-o-Y growth Comparison, By Region. 18

       3.1.2. CTC Tests Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 19

                3.1.2.1. Revenue (US$ Mn) Comparison, By Region. 19

                3.1.2.2. Market Share Comparison, By Region. 21

                3.1.2.3. Y-o-Y growth Comparison, By Region. 21

       3.1.3. Immunohistochemistry Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 22

                3.1.3.1. Revenue (US$ Mn) Comparison, By Region. 22

                3.1.3.2. Market Share Comparison, By Region. 24

                3.1.3.3. Y-o-Y growth Comparison, By Region. 24

       3.1.4. PCA3 test Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 25

                3.1.4.1. Revenue (US$ Mn) Comparison, By Region. 25

                3.1.4.2. Market Share Comparison, By Region. 27

                3.1.4.3. Y-o-Y growth Comparison, By Region. 27

       3.1.5. Others Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 28

                3.1.5.1. Revenue (US$ Mn) Comparison, By Region. 28

                3.1.5.2. Market Share Comparison, By Region. 30

                3.1.5.3. Y-o-Y growth Comparison, By Region. 30

Chapter 4. Global Prostate Cancer Diagnostics Market Analysis and Forecast By End User. 32

4.1. Global Prostate Cancer Diagnostics Market Size and Forecast By End User, 2016-2031. 32

       4.1.1. Hospital Associated Labs Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 32

                4.1.1.1. Revenue (US$ Mn) Comparison, By Region. 32

                4.1.1.2. Market Share Comparison, By Region. 34

                4.1.1.3. Y-o-Y growth Comparison, By Region. 34

       4.1.2. Independent Diagnostic Laboratories Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 35

                4.1.2.1. Revenue (US$ Mn) Comparison, By Region. 35

                4.1.2.2. Market Share Comparison, By Region. 37

                4.1.2.3. Y-o-Y growth Comparison, By Region. 37

       4.1.3. Cancer Research Institutes Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 38

                4.1.3.1. Revenue (US$ Mn) Comparison, By Region. 38

                4.1.3.2. Market Share Comparison, By Region. 40

                4.1.3.3. Y-o-Y growth Comparison, By Region. 40

       4.1.4. Others Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 41

                4.1.4.1. Revenue (US$ Mn) Comparison, By Region. 41

                4.1.4.2. Market Share Comparison, By Region. 43

                4.1.4.3. Y-o-Y growth Comparison, By Region. 43

Chapter 5. Global Prostate Cancer Diagnostics Market Analysis and Forecast By Region. 45

5.1. Global Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 45

       5.1.1. North America Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 45

                5.1.1.1. Revenue (US$ Mn) Comparison, By Test Type. 45

                5.1.1.2. Revenue (US$ Mn) Comparison, By End User. 46

       5.1.2. Latin America Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 48

                5.1.2.1. Revenue (US$ Mn) Comparison, By Test Type. 48

                5.1.2.2. Revenue (US$ Mn) Comparison, By End User. 50

       5.1.3. Europe Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 52

                5.1.3.1. Revenue (US$ Mn) Comparison, By Test Type. 52

                5.1.3.2. Revenue (US$ Mn) Comparison, By End User. 53

       5.1.4. Japan Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 55

                5.1.4.1. Revenue (US$ Mn) Comparison, By Test Type. 55

                5.1.4.2. Revenue (US$ Mn) Comparison, By End User. 57

       5.1.5. APEJ Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 58

                5.1.5.1. Revenue (US$ Mn) Comparison, By Test Type. 58

                5.1.5.2. Revenue (US$ Mn) Comparison, By End User. 60

       5.1.6. MEA Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 62

                5.1.6.1. Revenue (US$ Mn) Comparison, By Test Type. 62

                5.1.6.2. Revenue (US$ Mn) Comparison, By End User. 63

Chapter 6. North America Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 66

6.1. US Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 66

       6.1.1. Revenue (US$ Mn) Comparison, By Test Type. 66

       6.1.2. Revenue (US$ Mn) Comparison, By End User. 67

6.2. Canada Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 68

       6.2.1. Revenue (US$ Mn) Comparison, By Test Type. 68

       6.2.2. Revenue (US$ Mn) Comparison, By End User. 69

Chapter 7. Latin America Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 70

7.1. Brazil Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 70

       7.1.1. Revenue (US$ Mn) Comparison, By Test Type. 70

       7.1.2. Revenue (US$ Mn) Comparison, By End User. 71

7.2. Mexico Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 72

       7.2.1. Revenue (US$ Mn) Comparison, By Test Type. 72

       7.2.2. Revenue (US$ Mn) Comparison, By End User. 73

7.3. Argentina Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 74

       7.3.1. Revenue (US$ Mn) Comparison, By Test Type. 74

       7.3.2. Revenue (US$ Mn) Comparison, By End User. 75

Chapter 8. Europe Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 76

8.1. Germany Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 76

       8.1.1. Revenue (US$ Mn) Comparison, By Test Type. 76

       8.1.2. Revenue (US$ Mn) Comparison, By End User. 77

8.2. UK Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 78

       8.2.1. Revenue (US$ Mn) Comparison, By Test Type. 78

       8.2.2. Revenue (US$ Mn) Comparison, By End User. 79

8.3. France Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 80

       8.3.1. Revenue (US$ Mn) Comparison, By Test Type. 80

       8.3.2. Revenue (US$ Mn) Comparison, By End User. 81

8.4. Spain Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 82

       8.4.1. Revenue (US$ Mn) Comparison, By Test Type. 82

       8.4.2. Revenue (US$ Mn) Comparison, By End User. 83

8.5. Italy Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 84

       8.5.1. Revenue (US$ Mn) Comparison, By Test Type. 84

       8.5.2. Revenue (US$ Mn) Comparison, By End User. 85

8.6. Nordic Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 86

       8.6.1. Revenue (US$ Mn) Comparison, By Test Type. 86

       8.6.2. Revenue (US$ Mn) Comparison, By End User. 87

Chapter 9. Japan Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 88

9.1. Japan Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 88

       9.1.1. Revenue (US$ Mn) Comparison, By Test Type. 88

       9.1.2. Revenue (US$ Mn) Comparison, By End User. 89

Chapter 10. APEJ Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 90

10.1. China Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 90

       10.1.1. Revenue (US$ Mn) Comparison, By Test Type. 90

       10.1.2. Revenue (US$ Mn) Comparison, By End User. 91

10.2. India Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 92

       10.2.1. Revenue (US$ Mn) Comparison, By Test Type. 92

       10.2.2. Revenue (US$ Mn) Comparison, By End User. 93

10.3. Malaysia Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 94

       10.3.1. Revenue (US$ Mn) Comparison, By Test Type. 94

       10.3.2. Revenue (US$ Mn) Comparison, By End User. 95

10.4. Thailand Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 96

       10.4.1. Revenue (US$ Mn) Comparison, By Test Type. 96

       10.4.2. Revenue (US$ Mn) Comparison, By End User. 97

10.5. Singapore Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 98

       10.5.1. Revenue (US$ Mn) Comparison, By Test Type. 98

       10.5.2. Revenue (US$ Mn) Comparison, By End User. 99

10.6. Australia Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 100

       10.6.1. Revenue (US$ Mn) Comparison, By Test Type. 100

       10.6.2. Revenue (US$ Mn) Comparison, By End User. 101

Chapter 11. MEA Prostate Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031. 102

11.1. GCC Countries Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 102

       11.1.1. Revenue (US$ Mn) Comparison, By Test Type. 102

       11.1.2. Revenue (US$ Mn) Comparison, By End User. 103

11.2. South Africa Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 104

       11.2.1. Revenue (US$ Mn) Comparison, By Test Type. 104

       11.2.2. Revenue (US$ Mn) Comparison, By End User. 105

11.3. Nigeria Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 106

       11.3.1. Revenue (US$ Mn) Comparison, By Test Type. 106

       11.3.2. Revenue (US$ Mn) Comparison, By End User. 107

11.4. Israel Prostate Cancer Diagnostics Market Size and Forecast, 2016-2031. 108

       11.4.1. Revenue (US$ Mn) Comparison, By Test Type. 108

       11.4.2. Revenue (US$ Mn) Comparison, By End User. 109

Chapter 12. Global Prostate Cancer Diagnostics Market Company/Manufactures/Distributors/Suppliers Profile and Revenue Projections. 110

12.1. Abbott Laboratories. 110

       12.1.1. Company Overview. 110

       12.1.2. Product Overview. 110

       12.1.3. Key Financials. 110

       12.1.4. Key Developments. 111

       12.1.5. SWOT Analysis. 111

12.2. AstraZeneca plc.. 112

       12.2.1. Company Overview. 112

       12.2.2. Product Overview. 112

       12.2.3. Key Financials. 112

       12.2.4. Key Developments. 112

       12.2.5. SWOT Analysis. 113

12.3. Bayer Aktiengesellschaft. 116

       12.3.1. Company Overview. 116

       12.3.2. Product Overview. 116

       12.3.3. Key Financials. 116

       12.3.4. Key Developments. 117

       12.3.5. SWOT Analysis. 117

12.4. Danaher Corporation. 120

       12.4.1. Company Overview. 120

       12.4.2. Product Overview. 120

       12.4.3. Key Financials. 121

       12.4.4. Key Developments. 121

       12.4.5. SWOT Analysis. 121

12.5. Becton, Dickinson and Company. 124

       12.5.1. Company Overview. 124

       12.5.2. Product Overview. 124

       12.5.3. Key Financials. 125

       12.5.4. Key Developments. 125

       12.5.5. SWOT Analysis. 125

12.6. Foundation Medicine, Inc.. 128

       12.6.1. Company Overview. 128

       12.6.2. Product Overview. 128

       12.6.3. Key Financials. 128

12.7. Cancer Genetics, Inc.. 129

       12.7.1. Company Overview. 129

       12.7.2. Product Overview. 129

       12.7.3. Key Financials. 129

       12.7.4. Key Developments. 130

12.8. Myriad Genetics Inc.. 131

       12.8.1. Company Overview. 131

       12.8.2. Product Overview. 131

       12.8.3. Key Financials. 132

       12.8.4. Key Developments. 132

       12.8.5. SWOT Analysis. 132

12.9. Agilent Technologies. 135

       12.9.1. Company Overview. 135

       12.9.2. Product Overview. 135

       12.9.3. Key Financials. 136

       12.9.4. Key Developments. 136

       12.9.5. SWOT Analysis. 136

12.10. Biocept, Inc.. 137

       12.10.1. Company Overview. 137

       12.10.2. Product Overview. 137

       12.10.3. Key Financials. 137

       12.10.4. Key Developments. 138

Chapter 13. Disclaimer and Contact information. 139

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

TABLE 1 Global Prostate Cancer Diagnostics Market Value (US$ Mn), 2016-2020 22

TABLE 2 Global Prostate Cancer Diagnostics Market Value (US$ Mn), 2021-2031 23

TABLE 3 Global Prostate Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2018-2031 25

TABLE 4 Global PSA Tests Segment Value (US$ Mn), By Region 2016-2020 27

TABLE 5 Global PSA Tests Segment Value (US$ Mn), By Region 2021-2031 28

TABLE 6 Global PSA Tests Segment Market Share, By Region 2016-2020 29

TABLE 7 Global PSA Tests Segment Market Share, By Region 2021-2031 29

TABLE 8 Global PSA Tests Segment Y-o-Y, By Region 2018-2031 29

TABLE 9 Global CTC Tests Segment Value (US$ Mn), By Region 2016-2020 30

TABLE 10 Global CTC Tests Segment Value (US$ Mn), By Region 2021-2031 31

TABLE 11 Global CTC Tests Segment Market Share, By Region 2016-2020 32

TABLE 12 Global CTC Tests Segment Market Share, By Region 2021-2031 32

TABLE 13 Global CTC Tests Segment Y-o-Y, By Region 2018-2031 32

TABLE 14 Global Immunohistochemistry Segment Value (US$ Mn), By Region 2016-2020 33

TABLE 15 Global Immunohistochemistry Segment Value (US$ Mn), By Region 2021-2031 34

TABLE 16 Global Immunohistochemistry Segment Market Share, By Region 2016-2020 35

TABLE 17 Global Immunohistochemistry Segment Market Share, By Region 2021-2031 35

TABLE 18 Global Immunohistochemistry Segment Y-o-Y, By Region 2018-2031 35

TABLE 19 Global PCA3 test Segment Value (US$ Mn), By Region 2016-2020 36

TABLE 20 Global PCA3 test Segment Value (US$ Mn), By Region 2021-2031 37

TABLE 21 Global PCA3 test Segment Market Share, By Region 2016-2020 38

TABLE 22 Global PCA3 test Segment Market Share, By Region 2021-2031 38

TABLE 23 Global PCA3 test Segment Y-o-Y, By Region 2018-2031 38

TABLE 24 Global Others Segment Value (US$ Mn), By Region 2016-2020 39

TABLE 25 Global Others Segment Value (US$ Mn), By Region 2021-2031 40

TABLE 26 Global Others Segment Market Share, By Region 2016-2020 41

TABLE 27 Global Others Segment Market Share, By Region 2021-2031 41

TABLE 28 Global Others Segment Y-o-Y, By Region 2018-2031 41

TABLE 29 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2016-2020 43

TABLE 30 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2021-2031 44

TABLE 31 Global Hospital Associated Labs Segment Market Share, By Region 2016-2020 45

TABLE 32 Global Hospital Associated Labs Segment Market Share, By Region 2021-2031 45

TABLE 33 Global Hospital Associated Labs Segment Y-o-Y, By Region 2018-2031 45

TABLE 34 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2016-2020 46

TABLE 35 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2021-2031 47

TABLE 36 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2016-2020 48

TABLE 37 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2021-2031 48

TABLE 38 Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2018-2031 48

TABLE 39 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2016-2020 49

TABLE 40 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2021-2031 50

TABLE 41 Global Cancer Research Institutes Segment Market Share, By Region 2016-2020 51

TABLE 42 Global Cancer Research Institutes Segment Market Share, By Region 2021-2031 51

TABLE 43 Global Cancer Research Institutes Segment Y-o-Y, By Region 2018-2031 51

TABLE 44 Global Others Segment Value (US$ Mn), By Region 2016-2020 52

TABLE 45 Global Others Segment Value (US$ Mn), By Region 2021-2031 53

TABLE 46 Global Others Segment Market Share, By Region 2016-2020 54

TABLE 47 Global Others Segment Market Share, By Region 2021-2031 54

TABLE 48 Global Others Segment Y-o-Y, By Region 2018-2031 54

TABLE 49 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 56

TABLE 50 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 56

TABLE 51 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 57

TABLE 52 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 58

TABLE 53 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 59

TABLE 54 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 60

TABLE 55 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 61

TABLE 56 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 61

TABLE 57 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 63

TABLE 58 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 63

TABLE 59 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 64

TABLE 60 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 65

TABLE 61 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 66

TABLE 62 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 67

TABLE 63 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 68

TABLE 64 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 68

TABLE 65 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 69

TABLE 66 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 70

TABLE 67 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 71

TABLE 68 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 72

TABLE 69 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 73

TABLE 70 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 73

TABLE 71 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 74

TABLE 72 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 75

TABLE 73 US Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 77

TABLE 74 US Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 77

TABLE 75 US Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 78

TABLE 76 US Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 78

TABLE 77 Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 79

TABLE 78 Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 79

TABLE 79 Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 80

TABLE 80 Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 80

TABLE 81 Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 81

TABLE 82 Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 81

TABLE 83 Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 82

TABLE 84 Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 82

TABLE 85 Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 83

TABLE 86 Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 83

TABLE 87 Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 84

TABLE 88 Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 84

TABLE 89 Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 85

TABLE 90 Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 85

TABLE 91 Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 86

TABLE 92 Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 86

TABLE 93 Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 87

TABLE 94 Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 87

TABLE 95 Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 88

TABLE 96 Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 88

TABLE 97 UK Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 89

TABLE 98 UK Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 89

TABLE 99 UK Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 90

TABLE 100 UK Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 90

TABLE 101 France Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 91

TABLE 102 France Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 91

TABLE 103 France Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 92

TABLE 104 France Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 92

TABLE 105 Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 93

TABLE 106 Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 93

TABLE 107 Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 94

TABLE 108 Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 94

TABLE 109 Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 95

TABLE 110 Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 95

TABLE 111 Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 96

TABLE 112 Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 96

TABLE 113 Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 97

TABLE 114 Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 97

TABLE 115 Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 98

TABLE 116 Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 98

TABLE 117 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 99

TABLE 118 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 99

TABLE 119 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 100

TABLE 120 Japan  Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 100

TABLE 121 China Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 101

TABLE 122 China Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 101

TABLE 123 China Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 102

TABLE 124 China Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 102

TABLE 125 India Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 103

TABLE 126 India Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 103

TABLE 127 India Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 104

TABLE 128 India Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 104

TABLE 129 Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 105

TABLE 130 Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 105

TABLE 131 Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 106

TABLE 132 Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 106

TABLE 133 Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 107

TABLE 134 Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 107

TABLE 135 Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 108

TABLE 136 Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 108

TABLE 137 Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 109

TABLE 138 Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 109

TABLE 139 Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 110

TABLE 140 Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 110

TABLE 141 Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 111

TABLE 142 Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 111

TABLE 143 Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 112

TABLE 144 Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 112

TABLE 145 GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 113

TABLE 146 GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 113

TABLE 147 GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 114

TABLE 148 GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 114

TABLE 149 South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 115

TABLE 150 South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 115

TABLE 151 South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 116

TABLE 152 South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 116

TABLE 153 Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 117

TABLE 154 Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 117

TABLE 155 Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 118

TABLE 156 Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 118

TABLE 157 Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 119

TABLE 158 Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 119

TABLE 159 Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 120

TABLE 160 Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 120

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

FIG. 1 Global Prostate Cancer Diagnostics Market Value (US$ Mn), 2016-2020 15

FIG. 2 Global Prostate Cancer Diagnostics Market Value (US$ Mn) Forecast, 2021-2031 15

FIG. 3 Global Prostate Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2018-2031 17

FIG. 4 Global PSA Tests Segment Market Value (US$ Mn) By Region, 2016-2020 19

FIG. 5 Global PSA Tests Segment Market Value (US$ Mn) By Region, 2021-2031 20

FIG. 6 Global PSA Tests Segment Y-o-Y Growth Rate, By Region, 2018-2031 22

FIG. 7 Global CTC Tests Segment Market Value (US$ Mn) By Region, 2016-2020 22

FIG. 8 Global CTC Tests Segment Market Value (US$ Mn) By Region, 2021-2031 23

FIG. 9 Global CTC Tests Segment Y-o-Y Growth Rate, By Region, 2018-2031 25

FIG. 10 Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2016-2020 25

FIG. 11 Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2021-2031 26

FIG. 12 Global Immunohistochemistry Segment Y-o-Y Growth Rate, By Region, 2018-2031 28

FIG. 13 Global PCA3 test Segment Market Value (US$ Mn) By Region, 2016-2020 28

FIG. 14 Global PCA3 test Segment Market Value (US$ Mn) By Region, 2021-2031 29

FIG. 15 Global PCA3 test Segment Y-o-Y Growth Rate, By Region, 2018-2031 31

FIG. 16 Global Others Segment Market Value (US$ Mn) By Region, 2016-2020 31

FIG. 17 Global Others Segment Market Value (US$ Mn) By Region, 2021-2031 32

FIG. 18 Global Others Segment Y-o-Y Growth Rate, By Region, 2018-2031 34

FIG. 19 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2016-2020 35

FIG. 20 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2021-2031 36

FIG. 21 Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2018-2031 38

FIG. 22 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2016-2020 38

FIG. 23 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2021-2031 39

FIG. 24 Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2018-2031 41

FIG. 25 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2016-2020 41

FIG. 26 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2021-2031 42

FIG. 27 Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2018-2031 44

FIG. 28 Global Others Segment Market Value (US$ Mn) By Region, 2016-2020 44

FIG. 29 Global Others Segment Market Value (US$ Mn) By Region, 2021-2031 45

FIG. 30 Global Others Segment Y-o-Y Growth Rate, By Region, 2018-2031 47

FIG. 31 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 48

FIG. 32 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 49

FIG. 33 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 50

FIG. 34 North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 50

FIG. 35 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 51

FIG. 36 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 52

FIG. 37 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 53

FIG. 38 Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 54

FIG. 39 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 55

FIG. 40 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 56

FIG. 41 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 57

FIG. 42 Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 57

FIG. 43 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 58

FIG. 44 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 59

FIG. 45 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 60

FIG. 46 Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 61

FIG. 47 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 62

FIG. 48 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 62

FIG. 49 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 63

FIG. 50 APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 64

FIG. 51 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 65

FIG. 52 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 66

FIG. 53 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 67

FIG. 54 MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 67

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Prostate Cancer Diagnostics Market

Schedule a Call

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services